JW Pharmaceutical Corp (001067) — Cash Flow Quality Index
JW Pharmaceutical Corp (001067) has a Cash Flow Quality Index of 1.53x as of September 2025. Operating cash flow of ₩46.92 Billion exceeds net income of ₩30.59 Billion, indicating high earnings quality where cash backs reported profits. Explore JW Pharmaceutical Corp (001067) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
JW Pharmaceutical Corp Cash Flow Quality Index (2015–2024)
Historical Cash Flow Quality Index for JW Pharmaceutical Corp across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 001067 cash generation efficiency.
Annual Cash Flow Quality Index for JW Pharmaceutical Corp (2015–2024)
Year-by-year earnings quality comparison for JW Pharmaceutical Corp.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.22x | ₩79.39 Billion | ₩65.04 Billion | ▼ -51.2% |
| 2023 | 2.50x | ₩87.16 Billion | ₩34.84 Billion | ▲ +47.8% |
| 2022 | 1.69x | ₩56.76 Billion | ₩33.55 Billion | ▼ -73.8% |
| 2018 | 6.47x | ₩52.11 Billion | ₩8.06 Billion | ▲ +403.9% |
| 2015 | -2.13x | ₩-4.17 Billion | ₩1.96 Billion | — |